These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34488880)

  • 41. Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes.
    Dalfrà MG; Chilelli NC; Di Cianni G; Mello G; Lencioni C; Biagioni S; Scalese M; Sartore G; Lapolla A
    Int J Endocrinol; 2013; 2013():279021. PubMed ID: 24319455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving glucose control in patients with type 2 diabetes using retrospective continuous glucose monitoring.
    Diamond K
    J Am Assoc Nurse Pract; 2023 Jul; 35(7):425-433. PubMed ID: 36735841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs.
    Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Lin SY; Sheu WH
    Ther Adv Chronic Dis; 2021; 12():20406223211033674. PubMed ID: 34394904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating perioperative glycemic status after different types of pancreatic surgeries via continuous glucose monitoring system: a pilot study.
    Mao Y; Zhao X; Zhou L; Lu B; Jin C; Fu D; Yao L; Li J
    Gland Surg; 2021 Oct; 10(10):2945-2955. PubMed ID: 34804882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mean amplitude of glycemic excursions in septic patients and its association with outcomes: A prospective observational study using continuous glucose monitoring.
    Furushima N; Egi M; Obata N; Sato H; Mizobuchi S
    J Crit Care; 2021 Jun; 63():218-222. PubMed ID: 32958351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Point-of-Care and Laboratory Glycated Hemoglobin A1c and Its Relationship to Time-in-Range and Glucose Variability: A Real-World Study.
    Al Hayek A; Alzahrani WM; Sobki SH; Al-Saeed AH; Al Dawish M
    Cureus; 2023 Jan; 15(1):e33416. PubMed ID: 36643084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. THE EFFECT OF INCREASED ADHERENCE TO GLYCEMIC CONTROL ON CORONARY HEART DISEASE AND QUALITY OF LIFE IN PATIENTS WITH CONCOMITANT IMPAIRED GLUCOSE METABOLISM.
    Dzhun Y; Mankovsky G; Rudenko N; Mankovsky B; Marushko Y
    Georgian Med News; 2021 Sep; (318):86-93. PubMed ID: 34628385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemoglobin Wayne: A Rare Variant That Can Cause Falsely Elevated Hemoglobin A1c.
    Ao X; Ganta N; Choe S; Patel P; Turro J; Cheriyath P
    Cureus; 2022 Jul; 14(7):e26559. PubMed ID: 35936177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed.
    Neylon OM; Baghurst PA; Cameron FJ
    J Diabetes Sci Technol; 2014 Mar; 8(2):273-276. PubMed ID: 24876578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus.
    Qian J; Wang W; Wang L; Lu J; Zhang L; Zhang B; Wang S; Nie W; Zhang Y; Lou Y; Han B
    Front Oncol; 2021; 11():745150. PubMed ID: 34868942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus.
    Minami T; Ito Y; Yamada M; Furuta R; Minagawa F; Kamata K; Kameda A; Terauchi Y
    Diabetol Int; 2020 Apr; 11(2):114-120. PubMed ID: 32206481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Factors Associated with High Glycemic Variability Defined by Coefficient of Variation in Patients with Type 2 Diabetes.
    Gómez AM; Henao-Carillo DC; Taboada L; Fuentes O; Lucero O; Sanko A; Robledo MA; Muñoz O; Rondón M; García-Jaramillo M; León-Vargas F
    Med Devices (Auckl); 2021; 14():97-103. PubMed ID: 33833594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virtual visits and the use of continuous glucose monitoring for diabetes care in the era of COVID-19.
    Underwood P; Hibben J; Gibson J; DiNardo M
    J Am Assoc Nurse Pract; 2022 Mar; 34(3):586-596. PubMed ID: 34907992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Glucose-at-a-Glance": New Method to Visualize the Dynamics of Continuous Glucose Monitoring Data.
    Henriques T; Munshi MN; Segal AR; Costa MD; Goldberger AL
    J Diabetes Sci Technol; 2014 Mar; 8(2):299-306. PubMed ID: 24876582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study.
    Boutsen L; Costenoble E; Pollé O; Erdem K; Bugli C; Lysy PA
    Ther Adv Endocrinol Metab; 2023; 14():20420188221145550. PubMed ID: 36699944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nerve conduction study of the association between glycemic variability and diabetes neuropathy.
    Akaza M; Akaza I; Kanouchi T; Sasano T; Sumi Y; Yokota T
    Diabetol Metab Syndr; 2018; 10():69. PubMed ID: 30214502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of Time in Range Associated With HbA1c ≤7% in a Prospective Cohort of Patients With Type 1 Diabetes Using Continuous Glucose Monitoring for Three Months.
    Gómez AM; Henao C DC; Rebolledo M; Jaramillo P PE; Muñoz V OM; Niño G LM; Yepes C CA
    J Diabetes Sci Technol; 2024 Mar; 18(2):345-350. PubMed ID: 35791440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring.
    Kushner PR; Kruger DF
    Clin Diabetes; 2020 Oct; 38(4):348-356. PubMed ID: 33132504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting Glycated Hemoglobin Through Continuous Glucose Monitoring in Real-Life Conditions: Improved Estimation Methods.
    Valenzano M; Cibrario Bertolotti I; Grassi G; Broglio F; Valenzano A
    J Diabetes Sci Technol; 2023 Jul; 17(4):998-1007. PubMed ID: 35287492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.